Dr. Jason A. Zell is a UC Irvine Health hematology-oncology specialist who focuses on the prevention and treatment of colon and other gastrointestinal cancers at the Chao Family Comprehensive Cancer Center.
Board-certified in internal medicine, hematology and medical oncology, he has received extramural research funding from the National Institutes of Health (NIH) to perform genetic epidemiology-based colorectal cancer research, and is principle investigator or co-investigator for several NIH-funded Phase 2 clinical trials involving patients with gastrointestinal malignancies.
Within SWOG, a clinical trials organization of the National Clinical Trials Network, Zell is the cancer control and prevention liaison to the gastrointestinal committee. Additionally, he is national principal investigator for S0820, a large multicenter, randomized Phase 3 trial involving risk reduction among resected colon cancer patients, which is supported by the NIH National Cancer Institute Division of Cancer Prevention, and conducted by SWOG. He has published more than 70 manuscripts and two book chapters.
Zell received his medical degree from Nova Southeastern University, Fort Lauderdale, Fla. He completed his internal medicine residency training and hematology-oncology fellowship at UC Irvine School of Medicine, via the American Board of Internal Medicine Research Pathway.
View this physician's academic profile ›
Speakers Bureau Topics
- Cancer Prevention: Diet, Lifestyle and Therapeutic Prevention
- Cancer Prevention: Epidemiology, Screening and Early Detection
- Colon Cancer: Multidisciplinary Management